Methodological Insights Into T-Cell Activation: CD3/CD28 Versus PMA/Ionomycin Stimulation.

Area of Science:

• Immunology
• Cellular Signaling
• Molecular Biology

Background:

• T-cell activation is crucial for adaptive immunity.
• Distinct stimuli can elicit different cellular responses.
• Understanding T-cell activation pathways informs therapeutic strategies.

Purpose of the Study:

• To compare the distinct signaling programs induced by pharmacological (PMA/ionomycin) and receptor-mediated (CD3/CD28) stimulation in primary human T cells.
• To elucidate the mechanistic differences in T-cell responses to these activation methods.

Main Methods:

• Primary human T cells were stimulated using PMA/ionomycin and CD3/CD28 antibodies.
• Signaling pathway activation (ERK, IL-2/STAT5) and cellular responses (proliferation, CD25 upregulation) were analyzed.

Main Results:

• CD3/CD28 stimulation activated both ERK and IL-2/STAT5 signaling pathways.
• PMA/ionomycin predominantly induced ERK-dependent proliferation, despite robust IL-2 production and CD25 upregulation.
• Distinct signaling profiles were observed between the two activation methods.

Conclusions:

• Pharmacological and receptor-mediated T-cell activation induce fundamentally different signaling programs.
• Methodological choices significantly impact observed T-cell activation outcomes.
• These findings highlight mechanistic differences critical for interpreting T-cell activation studies.